Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v11-EN | Version v2-FR | |
|---|---|---|
| Language (Changed) | Updated to: English | Was: French |
| Date Updated (Changed) | Updated to: 2026-03-18 | Was: 2026-03-04 |
| Drug Identification Number | 02498049 | 02498049 |
| Brand name | IBSRELA | IBSRELA |
| Common or Proper name | TENAPANOR | TENAPANOR |
| Company Name | KNIGHT THERAPEUTICS INC. | KNIGHT THERAPEUTICS INC. |
| Ingredients | TENAPANOR | TENAPANOR |
| Strength(s) | 50MG | 50MG |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 75 mL HDPE bottle | 75 mL HDPE bottle |
| Additional packaging sizes | ||
| ATC code | A06AX | A06AX |
| ATC description | ||
| Reason for shortage | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated start date (Changed) | Updated to: 2026-03-31 | Was: 2023-03-31 |
| Actual start date | ||
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status (Changed) | Updated to: Anticipated shortage | Was: Actual shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: Supply Interruption | Was: Business Reason |
| Health Canada comments |